Cargando…
Decision analysis about the cost-effectiveness of different in vitro fertilization-embryo transfer protocol under considering governments, hospitals, and patient
OBJECTIVE: The aim of this study was to explore the benefits of in vitro fertilization (IVF) for patients and hospitals under different protocols and if IVF treatment should be incorporated into health care. PERSPECTIVE: The government should consider including IVF treatment in health insurance. Hos...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531099/ https://www.ncbi.nlm.nih.gov/pubmed/31083186 http://dx.doi.org/10.1097/MD.0000000000015492 |
_version_ | 1783420755206209536 |
---|---|
author | Pan, Wei Tu, Haiting Jin, Lei Hu, Cheng Li, Yuehan Wang, Renjie Huang, Weiming Liao, ShuJie |
author_facet | Pan, Wei Tu, Haiting Jin, Lei Hu, Cheng Li, Yuehan Wang, Renjie Huang, Weiming Liao, ShuJie |
author_sort | Pan, Wei |
collection | PubMed |
description | OBJECTIVE: The aim of this study was to explore the benefits of in vitro fertilization (IVF) for patients and hospitals under different protocols and if IVF treatment should be incorporated into health care. PERSPECTIVE: The government should consider including IVF treatment in health insurance. Hospitals and patients could obtain the best benefit by following the hospital's recommended protocol. SETTING: This retrospective study was conducted from January 2014 to August 2017 at an academic hospital. METHODS: A total of 7440 patients used gonadotropin-releasing hormone agonists (GnRHa) protocol, 2619 patients used, gonadotropin-releasing hormone antagonists (GnRHant) protocol, and 1514 patients used GnRHa ultra-long protocol. Primary outcomes were live birth rate (LBR), cost-effectiveness, hospital revenue, and government investment. RESULTS: The cycle times for the GnRHa protocol and the GnRHa ultra-long protocol were significantly higher than the GnRHant protocol. Patients who were ≤29 years chose the GnRHant protocol. The cost of a successful cycle was 67,579.39 ± 9,917.55 ¥ and LBR was 29.25%. Patients who were >30 years had the GnRHa protocol as the dominant strategy, as it was more effective at lower costs and higher LBR. When patients were >30 to ≤34 years, the cost of a successful cycle was 66,556.7 ± 8,448.08 ¥ and the LBR was 31.05%. When patients were >35 years, the cost of a successful cycle was 83,297.92 ± 10,918.05 ¥ and the LBR was 25.07%. The government reimbursement for a cycle ranged between 11,372.12 ± 2,147.71 ¥ and 12,753.67 ± 1,905.02 ¥. CONCLUSIONS: The government should consider including IVF treatment in health insurance. Hospitals recommend the GnRHant protocol for patients <29 years old and the GnRHa protocol for patients >30 years old, to obtain the best benefits. Patients could obtain the best benefit by using the protocol recommended by the hospital. |
format | Online Article Text |
id | pubmed-6531099 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-65310992019-06-25 Decision analysis about the cost-effectiveness of different in vitro fertilization-embryo transfer protocol under considering governments, hospitals, and patient Pan, Wei Tu, Haiting Jin, Lei Hu, Cheng Li, Yuehan Wang, Renjie Huang, Weiming Liao, ShuJie Medicine (Baltimore) Research Article OBJECTIVE: The aim of this study was to explore the benefits of in vitro fertilization (IVF) for patients and hospitals under different protocols and if IVF treatment should be incorporated into health care. PERSPECTIVE: The government should consider including IVF treatment in health insurance. Hospitals and patients could obtain the best benefit by following the hospital's recommended protocol. SETTING: This retrospective study was conducted from January 2014 to August 2017 at an academic hospital. METHODS: A total of 7440 patients used gonadotropin-releasing hormone agonists (GnRHa) protocol, 2619 patients used, gonadotropin-releasing hormone antagonists (GnRHant) protocol, and 1514 patients used GnRHa ultra-long protocol. Primary outcomes were live birth rate (LBR), cost-effectiveness, hospital revenue, and government investment. RESULTS: The cycle times for the GnRHa protocol and the GnRHa ultra-long protocol were significantly higher than the GnRHant protocol. Patients who were ≤29 years chose the GnRHant protocol. The cost of a successful cycle was 67,579.39 ± 9,917.55 ¥ and LBR was 29.25%. Patients who were >30 years had the GnRHa protocol as the dominant strategy, as it was more effective at lower costs and higher LBR. When patients were >30 to ≤34 years, the cost of a successful cycle was 66,556.7 ± 8,448.08 ¥ and the LBR was 31.05%. When patients were >35 years, the cost of a successful cycle was 83,297.92 ± 10,918.05 ¥ and the LBR was 25.07%. The government reimbursement for a cycle ranged between 11,372.12 ± 2,147.71 ¥ and 12,753.67 ± 1,905.02 ¥. CONCLUSIONS: The government should consider including IVF treatment in health insurance. Hospitals recommend the GnRHant protocol for patients <29 years old and the GnRHa protocol for patients >30 years old, to obtain the best benefits. Patients could obtain the best benefit by using the protocol recommended by the hospital. Wolters Kluwer Health 2019-05-13 /pmc/articles/PMC6531099/ /pubmed/31083186 http://dx.doi.org/10.1097/MD.0000000000015492 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 |
spellingShingle | Research Article Pan, Wei Tu, Haiting Jin, Lei Hu, Cheng Li, Yuehan Wang, Renjie Huang, Weiming Liao, ShuJie Decision analysis about the cost-effectiveness of different in vitro fertilization-embryo transfer protocol under considering governments, hospitals, and patient |
title | Decision analysis about the cost-effectiveness of different in vitro fertilization-embryo transfer protocol under considering governments, hospitals, and patient |
title_full | Decision analysis about the cost-effectiveness of different in vitro fertilization-embryo transfer protocol under considering governments, hospitals, and patient |
title_fullStr | Decision analysis about the cost-effectiveness of different in vitro fertilization-embryo transfer protocol under considering governments, hospitals, and patient |
title_full_unstemmed | Decision analysis about the cost-effectiveness of different in vitro fertilization-embryo transfer protocol under considering governments, hospitals, and patient |
title_short | Decision analysis about the cost-effectiveness of different in vitro fertilization-embryo transfer protocol under considering governments, hospitals, and patient |
title_sort | decision analysis about the cost-effectiveness of different in vitro fertilization-embryo transfer protocol under considering governments, hospitals, and patient |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531099/ https://www.ncbi.nlm.nih.gov/pubmed/31083186 http://dx.doi.org/10.1097/MD.0000000000015492 |
work_keys_str_mv | AT panwei decisionanalysisaboutthecosteffectivenessofdifferentinvitrofertilizationembryotransferprotocolunderconsideringgovernmentshospitalsandpatient AT tuhaiting decisionanalysisaboutthecosteffectivenessofdifferentinvitrofertilizationembryotransferprotocolunderconsideringgovernmentshospitalsandpatient AT jinlei decisionanalysisaboutthecosteffectivenessofdifferentinvitrofertilizationembryotransferprotocolunderconsideringgovernmentshospitalsandpatient AT hucheng decisionanalysisaboutthecosteffectivenessofdifferentinvitrofertilizationembryotransferprotocolunderconsideringgovernmentshospitalsandpatient AT liyuehan decisionanalysisaboutthecosteffectivenessofdifferentinvitrofertilizationembryotransferprotocolunderconsideringgovernmentshospitalsandpatient AT wangrenjie decisionanalysisaboutthecosteffectivenessofdifferentinvitrofertilizationembryotransferprotocolunderconsideringgovernmentshospitalsandpatient AT huangweiming decisionanalysisaboutthecosteffectivenessofdifferentinvitrofertilizationembryotransferprotocolunderconsideringgovernmentshospitalsandpatient AT liaoshujie decisionanalysisaboutthecosteffectivenessofdifferentinvitrofertilizationembryotransferprotocolunderconsideringgovernmentshospitalsandpatient |